BlackRock Fund Advisors - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 64 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$112,230,000
+14.8%
4,444,772
+12.5%
0.02%
+5.0%
Q3 2016$97,742,000
+54.8%
3,952,348
+27.5%
0.02%
+42.9%
Q2 2016$63,132,000
+46.4%
3,099,268
+9.6%
0.01%
+40.0%
Q1 2016$43,112,000
+14.7%
2,826,989
+1.1%
0.01%
+11.1%
Q4 2015$37,575,000
-4.8%
2,795,751
-0.6%
0.01%
-10.0%
Q3 2015$39,475,000
-6.4%
2,813,608
+13.3%
0.01%0.0%
Q2 2015$42,156,000
+157.0%
2,482,690
+83.0%
0.01%
+150.0%
Q1 2015$16,404,000
+48.1%
1,356,816
+1.7%
0.00%
+33.3%
Q4 2014$11,076,000
+5.0%
1,334,515
+9.9%
0.00%0.0%
Q3 2014$10,549,000
-20.1%
1,213,913
+0.7%
0.00%
-25.0%
Q2 2014$13,199,000
+51.3%
1,205,400
+23.6%
0.00%
+33.3%
Q1 2014$8,721,000
+40.4%
975,519
+18.4%
0.00%
+50.0%
Q4 2013$6,210,000
+12.4%
823,633
+9.3%
0.00%0.0%
Q3 2013$5,524,000
+31.2%
753,576
+15.1%
0.00%0.0%
Q2 2013$4,209,000654,6470.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders